Literature DB >> 26003044

G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.

Rong Qi1, Yan-Zhi Li2, Cong Chen3, Yi-Ni Cao3, Mao-Mao Yu3, Lu Xu3, Bing He4, Xu Jie3, Wen-Wen Shen3, Yu-Nan Wang3, Mallory A van Dongen5, Guo-Qing Liu3, Mark M Banaszak Holl5, Qiang Zhang4, Xue Ke6.   

Abstract

This work aimed to improve the oral bioavailability and plasma lipid-lowering effect of probucol (PB) by constructing a combined drug delivery system (CDDS) composed of nanostructured lipid carrier (NLC) and PEGylated poly(amidoamine) dendrimer (PEG-PAMAM). PEG-PAMAM with dendrimer generations of 5 (G5-PEG) or 7 (G7-PEG) were incorporated in PB-NLCs to form PB-CDDSs, PB-NLCs/G5-PEG and PB-NLCs/G7-PEG. The resultant two kinds of PB-CDDSs were characterized by particle size, zeta potential, drug encapsulation efficacy, PB release rates, and physical stability. Formulation effects of NLC and CDDS on the cellular uptake of hydrophobic drug were explored in Caco-2 cells by fluorescent Cy5 dye as a hydrophobic drug model. Furthermore, in vivo pharmacokinetics of the PB-CDDS composed of G5-PEG and PB-NLCs were investigated in a low density lipoprotein receptor knockout (LDLr-/-) mouse model, including plateau plasma PB concentrations after oral administration of multiple doses, and bioavailability after oral administration of a single dose of different PB formulations. In addition, lipid-lowering effect of PB-NLCs/G5-PEG was studied. The results indicate that both G5-PEG and G7-PEG significantly improved aqueous solubility of PB. The two PB-CDDSs exhibited similar particle size (around 150nm) as PB-NLCs, but slower PB burst release rate, higher total PB release amount, and better particle morphology and storage stability than PB-NLCs. In comparison with traditional NLC, CDDS dramatically enhanced cellular uptake of Cy5 into Caco-2 cells. In vivo results demonstrate that PB-NLCs/G5-PEG had the highest plateau plasma PB concentration and oral bioavailability, and the greatest cholesterol-lowering effect in comparison with PB suspensions and PB-NLCs. Therefore, G5-PEG incorporating NLC can be exploited as a promising drug delivery system to improve oral bioavailability and lipid-lowering effect of PB.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lipid-lowering effect; Nanostructured lipid carriers; Oral bioavailability; PEG-PAMAM dendrimers; Probucol; Water solubility

Mesh:

Substances:

Year:  2015        PMID: 26003044     DOI: 10.1016/j.jconrel.2015.05.281

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

Review 1.  Poly(amido amine) dendrimers in oral delivery.

Authors:  Venkata K Yellepeddi; Hamidreza Ghandehari
Journal:  Tissue Barriers       Date:  2016-04-06

2.  Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer.

Authors:  Chandraiah Godugu; Ravi Doddapaneni; Stephen H Safe; Mandip Singh
Journal:  Eur J Pharm Biopharm       Date:  2016-08-30       Impact factor: 5.571

Review 3.  Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.

Authors:  Jun Chen; Xixi Zhang; Reid Millican; Jennifer Sherwood; Sean Martin; Hanjoong Jo; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Adv Drug Deliv Rev       Date:  2021-01-09       Impact factor: 15.470

4.  Endocytic Uptake, Transport and Macromolecular Interactions of Anionic PAMAM Dendrimers within Lung Tissue.

Authors:  Christopher J Morris; Ghaith Aljayyoussi; Omar Mansour; Peter Griffiths; Mark Gumbleton
Journal:  Pharm Res       Date:  2017-06-14       Impact factor: 4.200

5.  Improved dissolution and oral absorption by co-grinding active drug probucol and ternary stabilizers mixtures with planetary beads-milling method.

Authors:  Fang Li; Linsen Li; Shaoning Wang; Yan Yang; Jia Li; Dongchun Liu; Sijie Zhang; Siling Wang; Hui Xu
Journal:  Asian J Pharm Sci       Date:  2018-12-12       Impact factor: 6.598

Review 6.  Polyamidoamine Dendrimers for Enhanced Solubility of Small Molecules and Other Desirable Properties for Site Specific Delivery: Insights from Experimental and Computational Studies.

Authors:  Daniel M Shadrack; Hulda S Swai; Joan J E Munissi; Egid B Mubofu; Stephen S Nyandoro
Journal:  Molecules       Date:  2018-06-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.